Literature DB >> 12502701

Docosahexaenoic acid but not eicosapentaenoic acid increases LDL particle size in treated hypertensive type 2 diabetic patients.

Richard J Woodman, Trevor A Mori, Valerie Burke, Ian B Puddey, Gerald F Watts, James D Best, Lawrence J Beilin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12502701     DOI： 10.2337/diacare.26.1.253

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  9 in total

Review 1.  Diet and low-density lipoprotein particle size.

Authors:  Sophie Desroches; Benoît Lamarche
Journal:  Curr Atheroscler Rep       Date:  2004-11       Impact factor: 5.113

Review 2.  Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.

Authors:  Richard J Woodman; Gerard T Chew; Gerald F Watts
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Algal docosahexaenoic acid affects plasma lipoprotein particle size distribution in overweight and obese adults.

Authors:  Lisa M Neff; Jill Culiner; Susanna Cunningham-Rundles; Cynthia Seidman; Diane Meehan; Janet Maturi; Knut M Wittkowski; Barbara Levine; Jan L Breslow
Journal:  J Nutr       Date:  2010-12-22       Impact factor: 4.798

Review 4.  A review of omega-3 ethyl esters for cardiovascular prevention and treatment of increased blood triglyceride levels.

Authors:  Clemens von Schacky
Journal:  Vasc Health Risk Manag       Date:  2006

Review 5.  Impact of DHA on metabolic diseases from womb to tomb.

Authors:  Ilse A C Arnoldussen; Amanda J Kiliaan
Journal:  Mar Drugs       Date:  2014-12-18       Impact factor: 5.118

Review 6.  Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.

Authors:  Jan Oscarsson; Eva Hurt-Camejo
Journal:  Lipids Health Dis       Date:  2017-08-10       Impact factor: 3.876

Review 7.  The Differential Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Cardiometabolic Risk Factors: A Systematic Review.

Authors:  Jacqueline K Innes; Philip C Calder
Journal:  Int J Mol Sci       Date:  2018-02-09       Impact factor: 5.923

Review 8.  Distinguishing health benefits of eicosapentaenoic and docosahexaenoic acids.

Authors:  Fraser D Russell; Corinna S Bürgin-Maunder
Journal:  Mar Drugs       Date:  2012-11-13       Impact factor: 5.118

Review 9.  Could Omega 3 Fatty Acids Preserve Muscle Health in Rheumatoid Arthritis?

Authors:  Kassandra Lanchais; Frederic Capel; Anne Tournadre
Journal:  Nutrients       Date:  2020-01-15       Impact factor: 5.717
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.